Mark Cuban, cofounder of the Mark Cuban Cost Plus Drug Co, wants to make so-called "specialty" drugs more accessible.

Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...

Shark Tank investor Mark Cuban loves to chase new ideas and ventures. As an owner of multiple ventures from different industries, the billionaire shark does not shy away from putting his money into ...

Nearly three years after its launch, Mark Cuban ... that," Mr. Cuban said, "Not much :)." With its model of selling medicines at cost plus a 15% markup and $10 for shipping and pharmacy labor ...

Revolutionizing Pharmacy Benefits ... thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being ...

With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are taking bold steps to ensure transparency and affordability within the pharmacy benefits arena.

PharmPix Corp. Joins Forces With Mark Cuban Cost Plus Drug Company to Revolutionize Pharmacy Benefits PharmPix, leveraging its cutting-edge OneArk® technology, empowers clients and their members ...

Mark Cuban speaks at a panel on Dec. 3 in San Francisco. Cuban says he has told hundreds of Fortune 500 executives, in one-on-one meetings and in groups, that they are overpaying on drug benefit plans ...

PharmPix Corp. Joins Forces With Mark Cuban Cost Plus Drug Company to Revolutionize Pharmacy Benefits PharmPix Corporation Wed, Dec 18, 2024, 7:00 AM 2 min read ...

This joint effort between PharmPix and Cost Plus Drugs brings together two forward-thinking organizations dedicated to reshaping the pharmacy landscape, providing unprecedented value to PharmPix ...

This joint effort between PharmPix and Cost Plus Drugs brings together two forward-thinking organizations dedicated to reshaping the pharmacy landscape, providing unprecedented value to PharmPix ...

Mark Cuban speaks at a panel on Dec. 3 in San Francisco. Cuban says he has told hundreds of Fortune 500 executives, in one-on-one meetings and in groups, that they are overpaying on drug benefit plans ...